9 | BMS 536924IBA
01/2012
-
09/2008 |
8 | Androgen Receptors (Androgen Receptor)IBA
01/2023
-
10/2005 |
6 | BMS 754807IBA
01/2012
-
12/2009 |
6 | Hormones (Hormone)IBA
12/2011
-
10/2005 |
5 | Insulin ReceptorIBA
01/2012
-
09/2008 |
5 | Tyrosine Kinase InhibitorsIBA
01/2012
-
01/2009 |
4 | AndrogensIBA
01/2021
-
06/2006 |
4 | Phosphotransferases (Kinase)IBA
01/2012
-
09/2010 |
4 | Insulin-Like PeptidesIBA
12/2011
-
01/2011 |
4 | AntibodiesIBA
04/2011
-
09/2010 |
4 | IGF Type 1 Receptor (IGF 1 Receptor)IBA
02/2011
-
01/2009 |
3 | LigandsIBA
01/2021
-
03/2003 |
3 | Insulin (Novolin)FDA Link
01/2012
-
01/2010 |
2 | Epidermal Growth Factor (EGF)IBA
01/2023
-
01/2011 |
2 | Mixed Function Oxygenases (Monooxygenases)IBA
11/2022
-
01/2016 |
2 | LyasesIBA
11/2022
-
01/2016 |
2 | Androgen Receptor AntagonistsIBA
01/2021
-
01/2021 |
2 | benzimidazoleIBA
01/2016
-
01/2011 |
2 | Proteins (Proteins, Gene)FDA Link
03/2012
-
01/2011 |
2 | Estrogens (Estrogen)FDA Link
12/2011
-
06/2006 |
2 | Insulin-Like Growth Factor I (IGF-1)IBA
04/2011
-
09/2008 |
2 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2011
-
11/2010 |
2 | Somatomedin Receptors (Somatomedin Receptor)IBA
01/2011
-
01/2009 |
2 | Biomarkers (Surrogate Marker)IBA
09/2010
-
01/2009 |
1 | Membrane Proteins (Integral Membrane Proteins)IBA
01/2023 |
1 | RNA (Ribonucleic Acid)IBA
01/2023 |
1 | Cadherins (E-Cadherin)IBA
01/2023 |
1 | Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA
11/2022 |
1 | XenobioticsIBA
11/2022 |
1 | AntigensIBA
01/2022 |
1 | JNJ-63576253IBA
01/2021 |
1 | compound 18IBA
01/2016 |
1 | Insulin-Like Growth Factor Binding ProteinsIBA
03/2012 |
1 | Insulin-Like Growth Factor Binding Protein 5IBA
03/2012 |
1 | Insulin-Like Growth Factor Binding Protein 4IBA
03/2012 |
1 | Dasatinib (BMS 354825)FDA Link
01/2012 |
1 | src-Family KinasesIBA
01/2012 |
1 | Tyrosine (L-Tyrosine)FDA Link
01/2012 |
1 | Cre recombinaseIBA
01/2012 |
1 | Antineoplastic Agents (Antineoplastics)IBA
12/2011 |
1 | TamoxifenFDA LinkGeneric
12/2011 |
1 | Letrozole (Femara)FDA LinkGeneric
12/2011 |
1 | Docetaxel (Taxotere)FDA Link
04/2011 |
1 | Phenobarbital (Luminal)FDA Link
02/2011 |
1 | matrigelIBA
02/2011 |
1 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2011 |
1 | ErbB Receptors (EGF Receptor)IBA
01/2011 |
1 | Fibronectins (Fibronectin)IBA
01/2011 |
1 | nimotuzumabIBA
01/2011 |
1 | Panitumumab (Vectibix)FDA Link
01/2011 |
1 | Cetuximab (Erbitux)FDA Link
01/2011 |
1 | Small Interfering RNA (siRNA)IBA
11/2010 |
1 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2010 |
1 | Ribosomal Protein S6IBA
11/2010 |
1 | Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
09/2010 |
1 | Transforming Growth Factor-beta Type I ReceptorIBA
09/2010 |
1 | Glucose (Dextrose)FDA LinkGeneric
01/2010 |
1 | 4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA
12/2009 |
1 | Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2009 |
1 | Caspase 3 (Caspase-3)IBA
12/2009 |
1 | 3-aminobenzamideIBA
11/2009 |
1 | Poly(ADP-ribose) Polymerase InhibitorsIBA
11/2009 |
1 | Androgen Antagonists (Antiandrogens)IBA
08/2009 |
1 | bicalutamide (Casodex)FDA LinkGeneric
08/2009 |
1 | BMS 641988IBA
08/2009 |
1 | BMS-554417IBA
09/2008 |
1 | (4- ((1- (3- fluorophenyl)methyl)- 1H- indazol- 5- ylamino)- 5- methylpyrrolo(2,1- f)(1,2,4)triazin- 6- yl)carbamic acid 3-morpholinylmethyl esterIBA
09/2008 |
1 | beta CateninIBA
01/2008 |
1 | Paclitaxel (Taxol)FDA LinkGeneric
06/2007 |
1 | Transaminases (Aminotransferases)IBA
06/2007 |
1 | 7- cyano- 2,3,4,5- tetrahydro- 1- (1H- imidazol- 4- ylmethyl)- 3- (phenylmethyl)- 4- (2- thienylsulfonyl)- 1H- 1,4- benzodiazepine (BMS 214662)IBA
06/2007 |